[go: up one dir, main page]

UA94080C2 - Ациклически-замещенные производные фуропиримидина и их применение для лечения сердечно-сосудистых заболеваний - Google Patents

Ациклически-замещенные производные фуропиримидина и их применение для лечения сердечно-сосудистых заболеваний

Info

Publication number
UA94080C2
UA94080C2 UAA200809519A UAA200809519A UA94080C2 UA 94080 C2 UA94080 C2 UA 94080C2 UA A200809519 A UAA200809519 A UA A200809519A UA A200809519 A UAA200809519 A UA A200809519A UA 94080 C2 UA94080 C2 UA 94080C2
Authority
UA
Ukraine
Prior art keywords
cardiovascular diseases
treating cardiovascular
acyclic substituted
treating
furopyrimidine derivatives
Prior art date
Application number
UAA200809519A
Other languages
English (en)
Ukrainian (uk)
Inventor
Томас Лампэ
Эва-Мария Беккер
Раимунд Каст
Хартмут Бекк
Марио Еске
Йоахим Шумахер
Фридерике ШТОЛЛЬ
Мартина КЛЯЙН
Метин АКБАБА
Андреас Кнорр
Йоханнес-Петер Шташ
Ларс Берфаккер
Александер Хиллиш
Гунтер Кариг
Марк Майнингхаус
Карл-Хайнц Шлеммер
Рудольф Шоэ-Лооп
Original Assignee
Баер Шеринг Фарма Акциэнгезельшафт
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Баер Шеринг Фарма Акциэнгезельшафт filed Critical Баер Шеринг Фарма Акциэнгезельшафт
Publication of UA94080C2 publication Critical patent/UA94080C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Данное изобретение касается новых ациклически замещенных производных фуропиримидина формулы (I), (I)способа их получения, их применения для лечения и/или профилактики заболеваний, а также их применения для получения лекарственных средств для лечения и/или профилактики заболеваний, в частности для лечения и/или профилактики сердечно-сосудистых заболеваний.
UAA200809519A 2005-12-21 2006-12-08 Ациклически-замещенные производные фуропиримидина и их применение для лечения сердечно-сосудистых заболеваний UA94080C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005061170A DE102005061170A1 (de) 2005-12-21 2005-12-21 Neue, acyclisch substituierte Furopyrimidin-Derivate und ihre Verwendung

Publications (1)

Publication Number Publication Date
UA94080C2 true UA94080C2 (ru) 2011-04-11

Family

ID=37876878

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200809519A UA94080C2 (ru) 2005-12-21 2006-12-08 Ациклически-замещенные производные фуропиримидина и их применение для лечения сердечно-сосудистых заболеваний

Country Status (31)

Country Link
US (1) US8183246B2 (ru)
EP (1) EP1966217B1 (ru)
JP (1) JP5254032B2 (ru)
KR (1) KR101429777B1 (ru)
CN (1) CN101384603B (ru)
AR (1) AR058108A1 (ru)
AU (1) AU2006334856B2 (ru)
BR (1) BRPI0620317A2 (ru)
CA (1) CA2633701C (ru)
CR (1) CR10092A (ru)
DE (1) DE102005061170A1 (ru)
DK (1) DK1966217T3 (ru)
DO (1) DOP2006000280A (ru)
EC (1) ECSP088569A (ru)
ES (1) ES2418855T3 (ru)
GT (1) GT200800117A (ru)
IL (1) IL192062A0 (ru)
MA (1) MA30039B1 (ru)
NO (1) NO20082986L (ru)
NZ (1) NZ569214A (ru)
PE (1) PE20071168A1 (ru)
PL (1) PL1966217T3 (ru)
PT (1) PT1966217E (ru)
RU (1) RU2454419C2 (ru)
SV (1) SV2009002953A (ru)
TN (1) TNSN08279A1 (ru)
TW (1) TWI405764B (ru)
UA (1) UA94080C2 (ru)
UY (1) UY30046A1 (ru)
WO (1) WO2007079862A1 (ru)
ZA (1) ZA200805385B (ru)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007019691A1 (de) * 2007-04-26 2008-10-30 Bayer Healthcare Ag Verwendung von acyclisch substituierten Furopyrimidin-Derivaten zur Behandlung der pulmonalen arteriellen Hypertonie
DE102007027799A1 (de) * 2007-06-16 2008-12-18 Bayer Healthcare Ag Substituierte Furopyrimidine und ihre Verwendung
DE102007051762A1 (de) 2007-10-30 2009-05-07 Bayer Healthcare Ag Substituierte Pyrrolotriazine und ihre Verwendung
DE102007054786A1 (de) 2007-11-16 2009-05-20 Bayer Healthcare Ag Trisubstituierte Furopyrimidine und ihre Verwendung
WO2013168760A1 (ja) 2012-05-10 2013-11-14 武田薬品工業株式会社 芳香環化合物
EP2848621A4 (en) 2012-05-10 2016-06-01 Takeda Pharmaceutical AROMATIC RING CONNECTION
EP3562828A1 (en) 2016-12-28 2019-11-06 Dart NeuroScience LLC Substituted pyrazolopyrimidinone compounds as pde2 inhibitors
WO2019104285A1 (en) 2017-11-27 2019-05-31 Dart Neuroscience, Llc Substituted furanopyrimidine compounds as pde1 inhibitors
PH12021552862A1 (en) 2019-05-13 2022-12-19 De Shaw Res Llc Fgfr inhibitors and methods of use thereof
KR102094337B1 (ko) 2019-10-01 2020-03-27 안문호 금속이물질 제거장치
TW202233625A (zh) 2020-11-18 2022-09-01 美商傳達治療有限公司 Ｆｇｆｒ抑制劑及其製造及使用方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3577420A (en) 1968-01-05 1971-05-04 Pfizer Certain 4-aminofuro(2,3-d)pyrimidines
ATE266662T1 (de) 1998-07-22 2004-05-15 Daiichi Suntory Pharma Co Ltd Nf-kappa b inhibitoren, die indanderivate als aktiven bestandteil enthalten
HK1045306A1 (zh) 1999-06-03 2002-11-22 Abbott Laboratories 抑制细胞黏附的抗炎化合物
AU7315400A (en) 1999-09-17 2001-04-24 Daiichi Suntory Pharma Co., Ltd Preventives or remedies for myocarditis, dilated cardiomyopathy and cardiac insufficiency containing NF-kappab inhibitors as the active ingredient
WO2002092603A1 (en) 2001-05-14 2002-11-21 Novartis Ag Oxazolo-and furopyrimidines and their use in medicaments against tumors
DE10141212A1 (de) * 2001-08-22 2003-03-06 Bayer Ag Neue 4-Aminofuropyrimidine und ihre Verwendung
WO2003022852A2 (en) 2001-09-11 2003-03-20 Smithkline Beecham Corporation Furo-and thienopyrimidine derivatives as angiogenesis inhibitors
DE10148883A1 (de) * 2001-10-04 2003-04-10 Merck Patent Gmbh Pyrimidinderivate
US20030225098A1 (en) * 2002-03-21 2003-12-04 Hirst Gavin C. Kinase inhibitors
KR20050091462A (ko) * 2004-03-12 2005-09-15 한국과학기술연구원 푸로피리미딘 화합물 및 이를 포함하는 ｄｄｒ2 티로신키나아제 활성 저해제
KR20070055486A (ko) 2004-06-10 2007-05-30 젠션 디스커버리 리미티드 포타슘 채널 억제제로서 유효한 퓨라노피리미딘 화합물
EP1768986A2 (en) 2004-06-29 2007-04-04 Amgen Inc. Furanopyrimidines

Also Published As

Publication number Publication date
GT200800117A (es) 2009-12-16
TNSN08279A1 (en) 2009-10-30
SV2009002953A (es) 2009-04-28
CA2633701C (en) 2014-05-27
IL192062A0 (en) 2008-12-29
NO20082986L (no) 2008-07-02
PL1966217T3 (pl) 2013-09-30
TWI405764B (zh) 2013-08-21
AU2006334856A1 (en) 2007-07-19
RU2454419C2 (ru) 2012-06-27
KR20080081323A (ko) 2008-09-09
JP2009520713A (ja) 2009-05-28
WO2007079862A1 (de) 2007-07-19
ZA200805385B (en) 2009-10-28
RU2008129363A (ru) 2010-01-27
DE102005061170A1 (de) 2007-07-05
CN101384603B (zh) 2012-08-01
DOP2006000280A (es) 2007-07-31
NZ569214A (en) 2011-07-29
KR101429777B1 (ko) 2014-08-19
CA2633701A1 (en) 2007-07-19
US20090318475A1 (en) 2009-12-24
ES2418855T3 (es) 2013-08-16
AU2006334856B2 (en) 2013-04-04
EP1966217A1 (de) 2008-09-10
DK1966217T3 (da) 2013-08-05
ECSP088569A (es) 2008-08-29
HK1130054A1 (en) 2009-12-18
BRPI0620317A2 (pt) 2011-11-08
TW200745132A (en) 2007-12-16
MA30039B1 (fr) 2008-12-01
JP5254032B2 (ja) 2013-08-07
PT1966217E (pt) 2013-07-12
US8183246B2 (en) 2012-05-22
EP1966217B1 (de) 2013-05-08
CN101384603A (zh) 2009-03-11
PE20071168A1 (es) 2008-02-07
CR10092A (es) 2008-10-08
AR058108A1 (es) 2008-01-23
UY30046A1 (es) 2007-07-31

Similar Documents

Publication Publication Date Title
WO2006021379A8 (de) Dihydropteridinonderivate, verfahren zu deren herstellung und deren verwendung als arzneimittel
MXPA05009068A (es) Dihidro-pteridinonas, metodo para la produccion y uso del mismo en la forma de farmacos.
WO2007015017A3 (fr) Nouveaux derives de polyquinoleines et leur utilisation therapeutique
WO2006021378A8 (de) Dihydropteridinonderivate, verfahren zu deren herstellung und deren verwendung als arzneimittel
TNSN06409A1 (en) Novel fluoroglycoside derivatives of pyrazoles, medicaments containing these compounds, and the use thereof
TNSN07360A1 (en) Substituted pyrrolo-pyridines, composition containing them, method for their producing and use thereof
TW200800968A (en) Sulfoximine-substituted pyrimidines, processes for production thereof and use thereof as drugs
MX2009003382A (es) Derivados de sulfonamidas sustituidos.
CY1110209T1 (el) Υποκατεστημενες ενωσεις βενζο(d)ισοξαζολ-3-υλ-αμινης σαν αναλγητικα
TW200736213A (en) Dicarboxylic acid derivatives and their use
MX2007002470A (es) Fenilaminotiazoles sustituidos y su uso.
MXPA05011707A (es) Dihidroquinazolinas sustituidas con propiedades antivirales.
MX2009007436A (es) Derivados espirociclicos de acido tetronico.
MX2007003031A (es) Compuestos heteroarilo para uso como betamimeticos en el tratamiento de enfermedades de vias respiratorias.
TW200640859A (en) Substituted bis aryl and heteroaryl compounds as selective 5HT2A antagonists
PL1891004T3 (pl) Pentafluorosulfanylo-podstawiony związek i jego zastosowanie do wytwarzania środków leczniczych
ATE519373T1 (de) Teezusammensetzung und herstellungsverfahren dafür
CY1109569T1 (el) Υποκατεστημενα παραγωγα κυκλοεξανο-1,4-διαμινης
MX2007000224A (es) Uso de 2-tio-3,5-diciano-4-fenil-6-aminopiridinas sustituidas en el tratamiento de nauseas y vomitos.
UA94080C2 (ru) Ациклически-замещенные производные фуропиримидина и их применение для лечения сердечно-сосудистых заболеваний
PL1758852T3 (pl) Podstawione związki cyklopentenu
TW200700064A (en) Novel compounds
SI1751093T1 (sl) Substituirani derivati cikloheksilocetne kisline
TW200716564A (en) Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
MX2007010400A (es) Nuevas sales de derivados de hexahidrofenantridina sustituida con 6-heterociclilo.